Free Trial

CRISPR Therapeutics (CRSP) SEC Filings & 10K Form

CRISPR Therapeutics logo
$52.16 +0.49 (+0.94%)
As of 01:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent CRISPR Therapeutics SEC Filings

DateFilerForm TypeView
06/26/2025
6:08 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:31 PM
CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 3/A
06/06/2025
4:38 PM
Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:47 PM
CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:20 PM
CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Fardis Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Rommel Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:45 PM
CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:45 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
9:52 AM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
05/13/2025
4:53 PM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
03/24/2025
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:05 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:05 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:05 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
10:23 AM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
01/10/2025
8:23 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
12/27/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
12:34 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
8:05 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
8:10 AM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Here's the last trade you should make before heading out for the weekend tomorrow. (Ad)

Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.

10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
5:00 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
5:00 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:45 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:22 PM
CRISPR Therapeutics (Filer)
Form S-3ASR
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRSP) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners